Brimson
Brimonidine Tartrate 0.2%
Added protection against vision loss through an IOP-independent mechanism
(American Journal of Ophthalmology 2011)
Healthcare Professionals login
Brimson
Brimonidine Tartrate 0.2%
Up to 6.2x better cardiac safety profile than timolol
(American Journal of Ophthalmology 1999)
View Research Library
Brimson
Brimonidine Tartrate 0.2%
Greater sterility assurance due to filling inside a barrier isolator
(WHO Good Manufacturing Practices 2011 | Pharmaceutical Manufacturing 2003)
Watch Video
Brimson
Brimonidine Tartrate 0.2%
Brimonidine Tartrate Eye Drops in medical-grade PE bottles manufactured inside barrier-isolator.
Each mL of solution contains 2mg of Brimonidine Tartrate.
Available in a pack of 5mL medical-grade PE bottle.
For topical use only.
Product Information
Indications
For reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension
Contraindications
Neonates and infants (under the age of 2 years)
Hypersensitivity to the active substance or any of the excipients
Adverse Effects
Oral dryness
Ocular hyperemia
Burning/Stinging
Dosage
Instil 1 drop in the affected eye(s), twice daily, approximately 12 hours apart.
Additional Information/ Precautions
Brimson should be used with caution in patients with depression, cerebral or coronary insufficiency, Raynaud’s phenomenon, orthostatic hypotension, thromboangiitis obliterans or severe cardiovascular disease.
For prescribing information,
Please Click Here
Previous
Next
Zoom In
Zoom Out
100%
Page:
/ 2
Member Log In
×
Mobile Number or Email Address
Receive Link
Not Registered? Please Sign Up
PMDC Number
Full Name
Email Address
Mobile Number
(e.g. 03xxxxxxxxx)
Hospital/Clinic Name & Address
Speciality
--Select--
GP
Consultant
Surgeon
Other
How Did You Hear About Us?
--Select--
Fellow doctor
Our representative
Other
Sign Up
